Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
28 Ottobre 2024 - 10:16PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
| ☐ |
Preliminary
Proxy Statement |
| |
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| |
|
| ☐ |
Definitive
Proxy Statement |
| |
|
| ☒ |
Definitive
Additional Materials |
| |
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12 |
CONDUIT PHARMACEUTICALS INC.
(Name
of Registrant as Specified in its Charter)
(Name
of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
| ☒ |
No fee required. |
| |
|
| ☐ |
Fee paid previously with preliminary materials |
| |
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Grafico Azioni Conduit Pharmaceuticals (NASDAQ:CDTTW)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Conduit Pharmaceuticals (NASDAQ:CDTTW)
Storico
Da Feb 2024 a Feb 2025
